Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ossium HPC Marrow
- Development stage
- Phase 1
- Lead developer
- Ossium Health
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
Ossium HPC Marrow is a cryopreserved, minimally manipulated hematopoietic progenitor cell (HPC) product derived from the bone marrow of vertebral bodies harvested from deceased organ donors. Developed by Ossium Health, it serves as an "off-the-shelf" allogeneic graft source for patients with hematologic malignancies (such as acute myeloid leukemia, acute lymphoblastic leukemia, and myelodysplastic syndrome) who lack suitable living HLA-matched donors. The product is processed using proprietary methods to maintain cell viability and is intended for hematopoietic reconstitution. It is currently being evaluated in the Phase 1 PRESERVE 1 clinical trial (NCT05589896) and the HOPE Expanded Access Program, and is also being studied as an adjunct to islet transplantation in Type 1 diabetes to improve glycemic control.
- Brand names
- Ossium HPC Marrow
- Other names
- HPC, MarrowOssium HPCdeceased donor bone marrowcryopreserved hematopoietic progenitor cells
Beyond the preview
Go deeper on Ossium HPC Marrow.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ossium HPC Marrow.